Cabatana, Josejem .

HRN: 26-63-17  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/01/2025
CEFTAZIDIME 1GM (VIAL)
02/01/2025
02/08/2025
IV
1G
Q8H
Pneumonia
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: